News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,569 Results
Type
Article (87015)
Company Profile (704)
Press Release (766843)
Multimedia
Podcasts (153)
Webinars (20)
Section
Business (232890)
Career Advice (4133)
Deals (39769)
Drug Delivery (130)
Drug Development (91140)
Employer Resources (199)
FDA (18211)
Job Trends (17373)
News (396983)
Policy (39846)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1616)
Antibody-drug conjugate (ADC) (192)
Approvals (18166)
Artificial intelligence (416)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (104)
Brain cancer (42)
Breast cancer (410)
Cancer (3239)
Cardiovascular disease (260)
Career advice (3542)
Career pathing (34)
CAR-T (216)
CDC (43)
Cell therapy (596)
Cervical cancer (25)
Clinical research (74522)
Collaboration (1161)
Company closure (3)
Compensation (758)
Complete response letters (42)
COVID-19 (2917)
CRISPR (70)
C-suite (401)
Cystic fibrosis (125)
Data (3291)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (387)
Diagnostics (6999)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (194)
Drug pricing (159)
Drug shortages (36)
Duchenne muscular dystrophy (164)
Earnings (97986)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131669)
Executive appointments (930)
FDA (20140)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1043)
Gene editing (153)
Generative AI (42)
Gene therapy (465)
GLP-1 (955)
Government (5295)
Grass and pollen (7)
Guidances (252)
Healthcare (20921)
HIV (46)
Huntington's disease (32)
IgA nephropathy (46)
Immunology and inflammation (195)
Immuno-oncology (15)
Indications (42)
Infectious disease (3123)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (131)
Interviews (813)
IPO (17907)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (61)
Layoffs (606)
Leadership (27)
Legal (10139)
Liver cancer (86)
Longevity (12)
Lung cancer (451)
Lymphoma (230)
Machine learning (14)
Management (65)
Manufacturing (485)
MASH (104)
Medical device (14754)
Medtech (14762)
Mergers & acquisitions (22622)
Metabolic disorders (986)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2416)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (501)
Opinion (295)
Ovarian cancer (108)
Pain (130)
Pancreatic cancer (135)
Parkinson's disease (206)
Partnered (25)
Patents (343)
Patient recruitment (194)
Peanut (55)
People (65823)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22990)
Phase II (32360)
Phase III (24367)
Pipeline (1847)
Policy (257)
Postmarket research (3554)
Preclinical (10388)
Press Release (72)
Prostate cancer (157)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (547)
Real estate (7402)
Recruiting (76)
Regulatory (27347)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (62)
Schizophrenia (106)
Series A (175)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (74)
The Weekly (97)
Vaccines (947)
Venture capital (62)
Weight loss (338)
Women's health (52)
Worklife (20)
Date
Today (205)
Last 7 days (642)
Last 30 days (2252)
Last 365 days (33857)
2025 (20108)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (72)
Alaska (7)
Arizona (282)
Arkansas (14)
Asia (50616)
Australia (8893)
California (8105)
Canada (2501)
China (753)
Colorado (346)
Connecticut (363)
Delaware (217)
Europe (116184)
Florida (1211)
Georgia (276)
Hawaii (3)
Idaho (67)
Illinois (761)
India (34)
Indiana (400)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1143)
Massachusetts (6219)
Michigan (281)
Minnesota (506)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2267)
New Mexico (31)
New York (2254)
North Carolina (1278)
North Dakota (10)
Northern California (3531)
Ohio (263)
Oklahoma (17)
Oregon (48)
Pennsylvania (1737)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (3021)
Tennessee (134)
Texas (1254)
United States (30552)
Utah (238)
Virginia (221)
Washington D.C. (80)
Washington State (710)
West Virginia (4)
Wisconsin (87)
There are 854,569 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Bayer Expects More Layoffs To Come Following a Brutal Two Years of Cost-Cutting
The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July 2023. Bayer said even more cuts are coming as it weathers up-and-down sales across its portfolio.
August 6, 2025
·
1 min read
·
Dan Samorodnitsky
Earnings
Terns Seeks Partners for Metabolic Assets Amid Oversaturated Obesity Market
Terns, once a rising star in obesity and the MASH space, will refocus on cancer and partner out a handful of obesity assets.
August 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Modeling Spinal Muscular Atrophy to Identify a Promising Therapy
August 6, 2025
·
1 min read
Earnings
‘Execution, Execution, Execution’: Novo’s New CEO Doubles Down on Obesity, Diabetes and Trims Pipeline
Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of reallocating resources to the company’s “main core” of metabolic disease.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CARTHERICS UNVEILS STATE-OF-THE-ART CLEANROOM FACILITY FOR CELL THERAPY MANUFACTURING
August 6, 2025
·
1 min read
Press Releases
Co-Founder of Velesco Pharmaceutical Appointed to Board of Directors at TSRL
The Preclinical CRO welcomes biopharma industry veteran Gerry Cox
August 6, 2025
·
1 min read
Press Releases
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
August 6, 2025
·
10 min read
Press Releases
Medexus Schedules First Fiscal Quarter 2026 Conference Call
August 6, 2025
·
3 min read
Press Releases
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference
August 6, 2025
·
4 min read
Tariffs
Trump Threatens Highest Pharma Tariffs So Far at 250%
President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within a year and a half.
August 6, 2025
·
2 min read
·
Tristan Manalac
1 of 85,457
Next
